Alprostadil (Prostaglandin E1)
Formulations: - Parenteral > General injections > IV: 0.5 mg per mL in alcohol Indications: - Other specified congenital anomaly of great arteries including arterial duct Source: EML workbook import
MOQ: 1
Kes0.00
Product image unavailable
Caffeine Citrate
Vendor: Marketplace supplier
Formulations:
- Parenteral > General injections > IV: 20 mg per mL (equivalent to 10 mg caffeine base per mL)
Oral > Liquid: 20 mg per mL (equivalent to 10 mg caffeine base per mL)
Indications:
- Apnoea of newborn
Source: EML workbook import
Product metadata will be available once the catalog entry is complete.
Kes0.00
Availability
Supplier and price will be confirmed during RFQ.
Formulations:
- Parenteral > General injections > IV: 20 mg per mL (equivalent to 10 mg caffeine base per mL)
Oral > Liquid: 20 mg per mL (equivalent to 10 mg caffeine base per mL)
Indications:
- Apnoea of newborn
Source: EML workbook import
Similar Products
Beractant
Formulations: - Respiratory > Suspension: 25 mg per mL for intratracheal instillation Indications: - Respiratory distress syndrome of newborn Source: EML workbook import
MOQ: 1
Kes0.00
Dinoprostone (Prostaglandin E2)
Formulations: - Parenteral > General injections > IV: 1 mg per mL Indications: - Other specified congenital anomaly of great arteries including arterial duct Source: EML workbook import
MOQ: 1
Kes0.00
Porcatant Alfa
Formulations: - Respiratory > Suspension: 80 mg per mL for intratracheal instillation Indications: - Respiratory distress syndrome of newborn Source: EML workbook import
MOQ: 1
Kes0.00
Sign Up to Our Newsletter→
Ready to amplify your rewards? Drop your email and we'll be in touch soon.